A revolutionary, single-procedure solution for pain-causing tendon, calcification, and bone spurs.

Tenex Health TX is FDA-cleared technology, offering a minimally invasive treatment for tendinopathy, calcific deposits, and hard tissue that takes only minutes to perform under local anesthesia.

Percutaneously cut and remove symptomatic soft and hard tissue.

In soft tissue procedures, Tenex can help patients heal rapidly with less discomfort, no stitches, and return to activity up to 4 times faster than open surgery.*
TX-Bone MicroTip (TXB) for hard tissue is designed specifically to remove bone and tissue found in tendinopathy with calcification, osteophytes, or spur formations.

Procedures using the Tenex Health TX® System are covered by most insurance.

A simple procedure.
A portable solution for any care setting.

The TX MicroTip is a disposable hand-held device available in three options: the TX1 MicroTip, TX2 MicroTip, and TX-Bone MicroTip.
TX MicroTip is utilized with the easy-to-use Tenex Health TX Console.

Clinical Studies

Our mission is to improve quality of life for patients experiencing chronic tendon pain. Published, submitted and accepted research by independent investigators provides evidence of the clinical and functional value of our definitive ultrasonic treatment for removal of diseased soft tissue and restoration of healthy musculoskeletal function.

Resources

Tenex Health TX Technology Overview

Patient Testimonial – Vanessa Fraser

Tenex Health TX System Sales Sheet

Powerful. Precise. Life-Changing.
Download

Tenex Health TX System Podiatry Sales Sheet

A Step Forward in the Minimally Invasive Treatment of Tendinopathy and Bony Prominences
Download

TX-Bone MicroTip Brochure

The Power to Heal Pain-Causing Bone, Calcific, and Soft Tissue

Download

Tenex Patient Brochure

Move Beyond Chronic Tendon and Bone Spur Pain
Download


Tenex Health, Inc. is the manufacturer of the Tenex Health TX® System.

For more information, visit tenexhealth.com

*Stuhlman C, et al. Current concepts and the role of surgery in the treatment of jumper’s knee. Orthopedics 2016;39(6):e1028-e1035.
**Cimino WW, Bond LJ. Ultrasound Med Biol 1996;22(1):89-100.; O’Daly BJ, et al. J of Mater Process Tech 2008;200(1-3):38-58.
†TXB has greater potential than TX1 or TX2 for faster and more tissue removal.

1. Baker CL, Mahoney JR. The Orthopaedic Journal of Sports Medicine 2020;8(3):1-8.; Battista CT, et al. Tech in Hand and Upper Extrem Surg 2018;22:15-18.; Chimenti RL, et al. J Ultrasound Med 2019;39(6):1629-1635.; Elattrache NS, Morrey BF. Operat Tech Orthop 2013;23(2):98-103.; Freed L, et al. J Am Podiatr Med Assoc. 2019;109(1):1-8.; Khanna M, et al. Poster presented at: Annual Meeting American Academy of Phys Medicine & Rehabilitation 2013 Oct.; Koh JSB, et al. Am J Sports Med 2013;41(3):636-644.; Patel MM, et al. J Orthop Rheum 2015;2(2):1014.; Patel MM. Am J of Orthop 2015;44(3):107-110.; Razdan R, Vander Woude E. J Surg Proced Tech 2018;3(102):1-6.; Seng C, et al. Am J Sports Med 2016;44(2):504-510.; Yanish GJ, et al. Submitted, J Shoulder Elbow Surg, 2019 Apr.
2. Stuhlman CR, et al. Orthopedics 2016;39(6):e1028-e1035.; Yanish GJ, et al. Submitted, J Shoulder Elbow Surg, 2019 Apr.
3. Nanos KN, Malanga GA. PM R 2015;7(12):1300-1305.
4. Kamineni S, et al. J Orth Surg Res 2015;10:70:1-8.
5. Sanders TL, et al. Am J Sports Med 2015;43(5):1066-1071.
Request Information